The purposes of this investigation were (1) to develop an in vivo method of determining the myocardium at risk after experimental coronary occlusion; (2) to define the spatial geometry of the salvageable ischemic border zone; and (3) to assess the ability of flurbiprofen, an antiinflammatory agent, to protect ischemic myocardium from necrosis. Twenty-two open-chest dogs underwent left anterior descending coronary artery occlusion and were randomized to treated (flurbiprofen 1 mg/kg i.v. at 30 minutes and 4 hours after occlusion; n = 11) or control (saline; n = 11) groups. Six hours after occlusion, methylene blue, 3 mI/kg, was injected into the left atrium, and immediately thereafter the hearts were removed and sliced transversely. Areas not perfused by methylene blue (area at risk [Ar]) were traced, planimetered, and compared to the area of necrosis (An) after incubation in triphenyltetrazolium chloride. The Ar for the two groups were similar (control 28.2 + 2.6%; treated 25.2 2.3% of total left ventricle; NS). In control dogs, An/Ar was 96.2 ± 0.7%, with similar values for the epicardium and endocardium. In treated dogs, An/Ar was 66.9 ± 8.9% (p < 0.001), with greater epicardial than endocardial salvage. Topographic superimposition of the An on the Ar showed that salvage occurred both on the epicardial and lateral aspects of the infarct.
NUMEROUS INTERVENTIONS have been shown in experimental animal studies to preserve myocardium otherwise destined to become necrotic as a result of reduced blood flow.'-" An important omission in many previous studies has been the estimation of the quantity of myocardium that would have been expected to become necrotic without the intervention being tested. The ability to salvage ischemic myocardium has been ascribed to numerous agents, based on a statistically smaller mean infarct size in treated animals compared with the control group. However, the marked variability even in the results of experiments in untreated animals makes this criterion less than adequate. More recently, investigators have attempted to define the myocardium at risk for each thin transverse section of left ventricle. ' 7 In most studies, radiopaque gels" or colored dyes7 were injected into the coronary arteries postmortem. In a few studies, dyes,8 pigmented neoprene latex, or highenergy technetium-labeled microspheres for auto-radiography9 were injected in vivo. Each method has advantages and drawbacks.
In addition to the problem of defining the area at risk, the definition, presence and geometry of a salvageable border zone are controversial. We consider the salvageable border zone to be the region of myocardium in which the cells remain viable as a result of treatment despite reductions of blood flow severe enough to lead to necrosis in untreated animals. With this definition, we studied the ability of flurbiprofen, a potent new antiinflammatory agent, which is a halogenated derivative of ibuprofen,10 to salvage the ischemic but potentially reversible border zone in the anesthetized dog, using an in vivo dye-perfusion method for assessing the myocardium at risk.
Methods
Thirty-one mongrel dogs of either sex that weighed [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] kg were anesthetized with thiamylal sodium (30 mg/kg i.v.), intubated, and ventilated with a Harvard respirator delivering room air with a tidal volume of 15 ml/kg. Thoracotomies were performed through the fifth left intercostal space. The lungs were retracted and the heart was suspended in a pericardial cradle. The left anterior descending coronary artery (LAD) was isolated from adjacent tissues immediately above the first diagonal branch but below the first major septal branch. A catheter was placed into the left atrium via an incision in the atrial appendage for injections of microspheres and dyes. A second catheter was placed in the left carotid artery for monitoring arterial pressure and for withdrawal of a reference blood sample during the injection of microspheres. A third catheter was placed into the left jugular vein and was used for i.v. injections.
The LAD was occluded with a clip above the first diagonal branch. All dogs received an i.v. bolus of lidocaine, 1.5 mg/kg, immediately after occlusion. 29 Fifteen minutes later, regional myocardial blood flow (RMBF) was determined by injecting approximately 2.0 X 106 radioactive microspheres labeled with 14"Ce or 1'3Sn (8-10 mu in diameter), as described previously." After the injection of microspheres, methylene blue, 1 ml/kg, was injected into the left atrium over 15 seconds to define an in vivo epicardial area at risk soon after coronary occlusion. The type of methylene blue used was not a pH indicator, and remained blue, at pH ranging from 2.0-9.0. The methylene blue was used only to differentiate between well-perfused and poorly perfused tissue. The region which was not perfused with methylene blue always coincided geographically with the area of epicardial cyanosis. The border between methylene blue-perfused epicardium and nonperfused epicardium was preserved by applying topical gentian violet, because methylene blue is not visible after 30 minutes. Dogs with an extremely small area of epicardial cyanosis (approximately < 9 cm2) as a result of extensive collateral flow from unoccluded vessels and dogs that had one or more episodes of ventricular fibrillation were excluded from further study.
Twenty-five minutes after occlusion of the LAD, the remaining dogs were randomized to treated or control group on the basis of a random odd or even number generated by a computer program. Thirty minutes and again 4 hours after occlusion, dogs received either flurbiprofen, 1 mg/kg, or saline, 1 ml/kg, intravenously. In four dogs in each group, the investigators were blinded to whether flurbiprofen or saline was given. Flurbiprofen was prepared as a l-mg/ml solution by dissolving the powder in saline at a pH of 9.0, lowering it to a physiologic pH, and then filtering the solution.
Six hours after occlusion, five dogs in each group had a second injection of microspheres (labeled with a different isotope) into the left atrium to determine whether flurbiprofen caused any change in RMBF during the 6-hour period. At the end of 6 hours, all dogs received a second left atrial injection of methylene blue, 3 ml/kg, infused over 30 seconds. Immediately thereafter, ventricular fibrillation or standstill was induced by an overdose of barbiturate and the hearts were then excised rapidly and placed on ice.
The right ventricle and fatty and valve tissue were dissected away and the left atrium and adjoining structures were separated from the left ventricle at the atrioventricular ring. The remaining left ventricular tissue was rapidly frozen in liquid freon and the left ventricle was sliced into six to nine (depending on the size of the heart) transverse sections, 5 mm thick, using a rotary blade, and were allowed to thaw. Clear glass plates were placed over both sides of each slice; epicardial and endocardial outlines as well as the methylene blue-perfused and nonperfused areas were traced on clear plastic sheets. To visualize the infarction, the slices were incubated in triphenyltetrazolium chloride (TTC) for 20 minutes at 37°C. Studies in our laboratory have shown that tissue that stains positive (red) in TTC after a 6-hour coronary occlusion is nor-mal by ultrastructural examination or shows only mild glycogen depletion and I bands; these are features of normal or reversibly injured tissue. In contrast, tissue that stains negative (white) in TTC after a 6-hour coronary occlusion shows severe mitochondrial edema, amorphous mitochondrial densities, nuclear chromatin clumping and sarcolemmal breaks, all features of irreversibly injured tissue.
Infarcted and noninfarcted areas on both sides of each slice were also traced on clear plastic sheets. The following information was obtained by computation using planimetric measurements of area and length: (1) the area at risk (Ar = ratio of areas not perfused by methylene blue to total areas of all slices); (2) area of necrosis (An = ratio of areas unstained by TTC to total areas of all slices); (3) the percentage of the total epicardial and endocardial circumferences at risk (epicardial and endocardial circumferences not stained by methylene blue); (4) the percentages of epicardial and endocardial circumferences at risk that became necrotic; and (5) original epicardial circumference at risk delineated by topical application of gentian violet. The endocardial and epicardial outlines were obviously not perfect circles; thus, their exact borders were traced with each enfolding carefully followed. The circumference values therefore represented the actual length of these wavy lines. The circumference at risk and circumference of necrotic tissue included only the unstained or necrotic tissue that actually touched the epicardium or endocardium.
Using the TTC-stained section with the plastic overlay of the area at risk as a guide, two slices of left ventricular tissue were dissected radially for analysis of RMBF from four zones ( fig. 1 ): the center of the in- farct (zone 1), tissue at the lateral margin of the area at risk (zone 2), tissue stained with methylene blue immediately adjacent to the lateral border of the area at risk (zone 3), and normal myocardium distant from the area at risk (zone 4). Each of these sections was further divided into inner (subendocardial half) and outer (subepicardial half) portions. The resultant pieces were weighed (all were 0.8-1.2 g) and counted separately in a gamma well counter for 10 minutes. RMBF for each piece of tissue and cardiac output were calculated as previously described.'1 12 Values for RMBF in each zone represented the average RMBF for that respective zone in the two slices of tissue analyzed.
Results
Of the original 31 dogs, six were eliminated from the study because of ventricular fibrillation in the first 20 minutes after occlusion and three were excluded because of a very small area of epicardium not perfused with methylene blue. Of the remaining 22 dogs, 11 were randomized to treated and 11 to control groups. None of these dogs had ventricular fibrillation during the study or episodes of prolonged ventricular tachycardia. The groups were similar with respect to mean weight (treated 24.6 ± 2.1 kg; control 22.5 ± 1.8 kg), dose of anesthesia used (30 mg/kg initially, followed by approximately 8 mg/kg during the next 6 hours), initial and terminal heart rates (treated 162 ± 8 beats/min; control 168 ± 6 beats/min, with no significant difference at 6 hours), mean arterial pressure (treated 122 ± 7 mm Hg; controls 118 ± 4 mm Hg, with no difference at 6 hours), dose of lidocaine (treated 116 + 4 mg; control 119 ± 5 mg) required to abolish premature ventricular complexes; and distance from the origin of the left coronary artery to the occlusion site (treated 21 ± 2 mm; controls 23 ± 2 mm).
Methylene blue stained the myocardium transmurally in regions of the left ventricle supplied by unoccluded coronary beds and did not stain the region of myocardium distal to and supplied by the occluded LAD. The cutoff between methylene blue-stained tissue and unstained tissue was sharply demarcated in all 22 dogs. Tissue incubated in TTC stained deep red if non-necrotic and pale yellow if necrotic. Necrotic tissue was always contained within the area not perfused with methylene blue.
The results of the study are summarized in table 1. The mean area at risk expressed as a percentage of the total left ventricle was not statistically different between treated (25.5 ± 3%) and control (28.2 i 1.6%; NS) dogs. However, the area of necrosis expressed as a percentage of the area at risk was considerably smaller in the treated dogs (66.9 + 8.9%) (SEM) than in control dogs (96.2 ± 0.7%; p < 0.001) ( fig. 2 ). Almost all of the myocardium at risk became necrotic after 6 hours of occlusion in untreated dogs, while in treated dogs, approximately a third of the area at risk did not become necrotic.
In treated dogs, more subepicardial tissue was salvaged (40.9 + 9.7% of circumference at risk) than subendocardial tissue (29.3 ± 9.4%). Although more subepicardial tissue was salvaged, the finding that almost 30% of the subendocardial circumference at risk was not bordered by necrotic tissue suggests that a lateral border zone of ischemic but potentially salvageable tissue exists. This was corroborated by two observations: (1) Superimposition of the Ar and Abbreviations: circ = circumference; LV = left ventricle; epi = epicardial; endo = endocardial; RMBF = regional myocardial blood flow. CI RCULATION 32 epicardial and lateral border zones of salvage; and (2) although RMBF was lowest in the central necrotic region (table 1) , it was always less than 0.4 ml/min/g within the area at risk, even at its most lateral margin. The tissue at the lateral margin but just within the area at risk was dissected in a manner to specifically exclude any necrotic tissue in flurbiprofen-treated dogs. In control dogs, part of the analagous piece of tissue was necrotic. Although this tissue was equally ischemic (flow < 0.4 ml/min/g) in both groups, it became necrotic in the control group but remained viable with flurbiprofen treatment. The tissue just outside the area at risk but just adjacent to its lateral margin generally had only minor reductions of blood flow, with values of 0.5-0.7 ml/min/g. Analysis of RMBF from microspheres injected before flurbiprofen administration and later before sacrifice showed no significant change in RMBF values in any portion of the tissue (table 2) .
It would be anticipated that the percentage of total left ventricle that became necrotic should be a function of the percentage of the left ventricle at risk, so the relationship between An and Ar for control and treated dogs was plotted ( fig. 3 ). In control dogs, the quantity of necrotic left ventricular tissue resulting from a 6-hour LAD occlusion correlated closely with the quantity of ischemic myocardium at risk. In contrast, there was a much lower correlation between these two variables and a significantly decreased slope of the regression line in treated dogs (p < 0.01), consistent with the observation that necrosis was diminished and that the ratio of An/Ar in treated dogs varied more than in the control dogs, presumably as a consequence of some variation in the extent of salvage in different dogs.
Discussion
From this study we conclude: (1) the absence of staining after in vivo injection of methylene blue into the left atrium after a 6-hour coronary occlusion delineates a region of the left ventricle characterized by RMBF less than 0.4 ml/min/g, and thus sufficiently ischemic to be at risk for necrosis. (2) A comparison of the shapes of the area at risk and area of necrosis in transverse ventricular slices from treated dogs demonstrates that ischemic but potentially There was no significant difference between any 15-minute value and its respective 6-hour value for RMBF (paired t test).
Abbreviations: RMBF = regional myocardial blood flow; epi = epicardial; endo = endocardial. salvageable tissue exists lateral to the most severely ischemic tissue; a much larger segment of this salvageable border zone is located at the epicardial than the endocardial aspect of the ventricle. (3) Flurbiprofen, a potent antiinflammatory drug,'0 can salvage approximately 30% of the ischemic tissue at risk for infarction in the anesthetized dog. Measurements of RMBF carried out immediately and 6 hours after coronary occlusion suggest flurbiprofen did not appear to cause any change in collateral blood flow.
Because of the large variability in the distribution of collateral vessels and in each dog's response to experimental coronary occlusion, future studies designed to assess the ability of an agent to salvage ischemic myocardium should also quantify the ischemic myocardium at risk for any experimental occlusion. Some investigators have felt that postmortem selective intracoronary injections of colored industrial dyes7 or barium gels6 provide the best assessment of myocardium at risk. However, the in vivo methylene blue method may be a more physiologic method than in vitro injections because (1) when all coronary arteries are perfused postmortem, the distribution of dye may differ from the perfusion of the myocardium in vivo when one coronary artery is occluded; (2) collateral flow between two coronary beds may not be appreciated in the dead heart in the absence of an occluded vessel; and (3) normal coronary flow is pulsatile and influenced by the changing intraventricular pressure so that the nonpulsatile flow produced by a postmortem infusion may not simulate in vivo flow patterns. Furthermore, an infusion of methylene blue into the left atrium in vivo delineates a physiologic region of myocardium at risk as opposed to an anatomic region defined by postmortem coronary injections. The accuracy of the methylene blue method for defining the ischemic bed is dependent on the arterial pressure and heart rate at the time of the second injection. However, in our experience, dogs that did not have long periods of ventricular tachycar-dia or ventricular bigeminy had no significant change in these variables between the first and second injection of methylene blue. In addition, flurbiprofen had no effect on heart rate, arterial pressure or RMBF.
Therefore, we feel that the in vivo method provides a physiologically meaningful delineation of the myocardium at risk for coronary occlusions of 6 hours or less.
Longer occlusions are often characterized by changes in RMBF; thus, the methylene blue method may not be applicable in these situations. Some,13 but not all,14 investigators have demonstrated a lateral border zone of potentially salvageable tissue. We feel that the discordant opinions may be the result of the way in which this question was assessed. The absence of an intermediate zone of creatine kinase depletion surrounding the zone of necrosis 24 hours after coronary occlusion has been proposed as evidence for the absence of a lateral border zone.l5 However, the extent of creatine kinase depletion and reduction of RMBF are not necessarily identical. Using our definition of a border zone, i.e. myocardium that remains viable with treatment despite a reduction in RMBF that leads to necrosis in untreated animals, the presence of ischemic but nonnecrotic tissue on the exterior and lateral margins of the zone of necrosis in treated dogs, and its absence in untreated control dogs indicates that such a zone exists both external (subepicardial) and lateral to the central ischemic zone. This conclusion is different from that proposed by Okun et al.,16 who feel that no lateral gradient of collateral blood flow exists within the ischemic bed. However, more recent studies from our laboratory suggest that a relatively large lateral region of collateral flow does exist at the margin of the ischemic bed.17' 18 Our findings suggest that if the border zone is not salvaged after coronary artery occlusion, necrosis progresses toward the subepicardium and laterally until it occupies almost all of the ischemic myocardium at risk.
How flurbiprofen salvages ischemic myocardium is ibuprofen, it may work in a similar manner. Ibuprofen interferes with the metabolism of arachidonic acid by inhibiting the enzyme cyclooxygenase, thus inhibiting the subsequent production of endoperoxides and prostaglandins PGE2 and PGF2a, which participate in the inflammatory process.'9 It also affects the kinin and histamine systems of mediating inflammation20 and, to a small degree, stabilizes lysosomal membranes, decreasing the amplification of the inflammatory process by lysosomal enzymes.2' Other effects include suppression of leukocyte motility and phago-cytosis22 and interference with platelet aggregation. 23 Whether flurbiprofen works in exactly the same manner and whether its efficacy in salvaging ischemic myocardium is a result of one or more of these mechanisms will be of interest for future investigations.
